Provided by Tiger Trade Technology Pte. Ltd.

LivaNova PLC

63.30
+0.90001.44%
Post-market: 63.300.00000.00%17:19 EDT
Volume:532.51K
Turnover:33.57M
Market Cap:3.46B
PE:-14.22
High:63.65
Open:63.24
Low:61.62
Close:62.40
52wk High:71.92
52wk Low:32.48
Shares:54.61M
Float Shares:54.41M
Volume Ratio:0.63
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4500
EPS(LYR):-4.4500
ROE:-19.24%
ROA:5.17%
PB:2.88
PE(LYR):-14.22

Loading ...

Stock Track | LivaNova Soars 8.74% as Strategic Roadmap Promises Strong Growth and Margin Expansion by 2030

Stock Track
·
Nov 13, 2025

LivaNova Unveils Strategic Roadmap Targeting High-Single-Digit Revenue Growth, Operating Margin Expansion, and Investment in Core and Emerging Markets by 2030

Reuters
·
Nov 13, 2025

LivaNova Plc - Targets High-Single-Digit-Plus Revenue Cagr by 2030

THOMSON REUTERS
·
Nov 13, 2025

LivaNova Plc - Osa Projected to Generate $200 Mln-$400 Mln Revenue by 2030

THOMSON REUTERS
·
Nov 13, 2025

LivaNova Plc - Targets EPS Cagr in Low Double Digits to Mid-Teens by 2030

THOMSON REUTERS
·
Nov 13, 2025

LivaNova Plc: Expects Osa Business to Be Break-Even by 2029

THOMSON REUTERS
·
Nov 13, 2025

LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day

THOMSON REUTERS
·
Nov 13, 2025

LivaNova (LIVN): Assessing Valuation After Strong Q3 Growth, Raised Guidance, and Innovation Milestones

Simply Wall St.
·
Nov 12, 2025

LivaNova Is Maintained at Outperform by Baird

Dow Jones
·
Nov 07, 2025

LivaNova Plc : Jefferies Raises Target Price to $86 From $80

THOMSON REUTERS
·
Nov 06, 2025

Is Rising Sales and a Swing to Net Loss Changing the Investment Case for LivaNova (LIVN)?

Simply Wall St.
·
Nov 06, 2025

Medical tech firm LivaNova beats Q3 revenue expectations, raises 2025 guidance

Reuters
·
Nov 05, 2025

LivaNova reports Q3 adjusted EPS $1.11, consensus 92c

TIPRANKS
·
Nov 05, 2025

LivaNova Q3 Adj. EPS $1.11 Beats $0.92 Estimate, Sales $357.800M Beat $343.505M Estimate

Benzinga
·
Nov 05, 2025

LivaNova Outlook FY Adjusted EPS USD 3.8-3.9

THOMSON REUTERS
·
Nov 05, 2025

LivaNova Outlook FY Revenue Growth 8.5-9.5%

THOMSON REUTERS
·
Nov 05, 2025

LivaNova Plc - Launches Essenz Perfusion System in China in Q3

THOMSON REUTERS
·
Nov 05, 2025

Press Release: LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance

Dow Jones
·
Nov 05, 2025

LivaNova (LIVN): Evaluating Valuation After Recent 23% Rally and Fresh Analyst Optimism

Simply Wall St.
·
Nov 04, 2025

The Bull Case For LivaNova (LIVN) Could Change Following Raised Full-Year Guidance and Strong Segment Growth

Simply Wall St.
·
Oct 23, 2025